Skip to main content

Clearside Biomedical, Inc.

CLSDDelisted Dec 8, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001539029

Clearside Biomedical, Inc. was delisted on Dec 8, 2025; its insiders filed their last Form 4 on Feb 24, 2025; 26 institutions reported holding it in 13F filings for Q3 2025, worth $2.18M in total; no superinvestor held it.

Q2 2025 vs. Q1 2025

How the institutions holding Clearside Biomedical, Inc. changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of CLSD: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders4445+1
Shares8.81M9.39M+573.6K (+6.5%)
Value$8.09M$7.51M−$581.4K (−7.2%)

New holders (6)

Institutions that held Clearside Biomedical, Inc. at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to CLSD in Q2 2025
InstitutionSharesValue% of portfolio
Gen-Wealth Partners Inc10,000$8.00K0.00%
Wells Fargo & Company6,000$4.80K0.00%
Royal Bank of Canada1,400$1.00K0.00%
Raymond James Financial Inc999$7990.00%
Allworth Financial LP50$400.00%
Simplex Trading, LLC127$00.00%

Sold out (5)

Institutions that held Clearside Biomedical, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of CLSD in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Prudential Financial Inc24,400$22.4K
Two Sigma Securities, LLC20,911$19.2K
Hudson Bay Capital Management LP18,411$16.9K
Advisor Resource Council15,000$13.8K
Larson Financial Group LLC1,000$918